Article

New analytic tools: backward compatibility enhances scanning laser tomography

Stability of technology is important when dealing with patients who have a progressive disease, said Balwantray Chauhan, PhD, professor and director of research, Department of Ophthalmology, Dalhousie University, Halifax, Nova Scotia.

Stability of technology is important when dealing with patients who have a progressive disease, said Balwantray Chauhan, PhD, professor and director of research, Department of Ophthalmology, Dalhousie University, Halifax, Nova Scotia.

When technology is continually upgraded, clinicians sometimes find that they are no longer able to view images taken years ago, which is clearly a disadvantage in dealing with slowly progressing conditions such as glaucoma, Dr. Chauhan said. Confocal scanning laser tomography (which was developed 25 years ago) lends itself to backward compatibility, however.

As a glaucoma specialist, Dr. Chauhan is interested in variability over a short period; when this is known, one can set limits that define change and establish criteria for change. Several techniques have been developed to help clinicians measure change with confocal scanning laser tomography.

Both statistic image mapping (SIM) and topographic change analysis (TCA) are effective techniques for detecting topographic change in series of images, Dr. Chauhan said.

"With both SIM and TCA, you can apply images that were captured in the early 1990s, for example, and start to reveal things that weren't really obvious at the time because of the backward compatibility," Dr. Chauhan said.

In evaluating images, it is also important to be able to correct for spatial correlation, Dr. Chauhan concluded. Doing so considerably decreases the amount of noise that may affect the accuracy of the interpretation.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
© 2025 MJH Life Sciences

All rights reserved.